EMEA-000471-PIP01-08-M02

Key facts

Invented name
Xelevia
Active substance
Sitagliptin (phosphate monohydrate)
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0128/2016
PIP number
EMEA-000471-PIP01-08-M02
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp and Dohme (Europe), Inc.
Belgium
Tel. +44 (0)1992 452396
Fax +44 (0)1992 468175
E-mail: paul.robinson@merck.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating